国家药监局-话题@MedSci

#国家药监局#

155篇内容 | 3560人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1429270, encodeId=dab114292e0dc, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局全新批准12款药品，3个首仿、2个首家通过一致性评价, objectType=article, longId=206577, objectId=6cf32065e7a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cf32065e7a4, replyNumber=0, likeNumber=84, createdTime=2021-02-03, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cf32065e7a4, moduleTitle=国家药监局全新批准12款药品，3个首仿、2个首家通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cf32065e7a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429269, encodeId=b9d1142926957, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局修订速效救心丸说明书，过敏者慎用, objectType=article, longId=206026, objectId=e44420602658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e44420602658, replyNumber=0, likeNumber=85, createdTime=2021-01-23, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e44420602658, moduleTitle=国家药监局修订速效救心丸说明书，过敏者慎用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e44420602658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429268, encodeId=fd2814292682d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局：已建设疫苗信息化追溯体系基本实现上市疫苗全程追溯管理, objectType=article, longId=205611, objectId=786f20561135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=786f20561135, replyNumber=0, likeNumber=74, createdTime=2021-01-12, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=786f20561135, moduleTitle=国家药监局：已建设疫苗信息化追溯体系基本实现上市疫苗全程追溯管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=786f20561135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429267, encodeId=84d2142926eb7, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局药品、器械审评检查长三角分中心在上海正式挂牌, objectType=article, longId=205470, objectId=ea302054e094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea302054e094, replyNumber=0, likeNumber=61, createdTime=2021-01-09, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea302054e094, moduleTitle=国家药监局药品、器械审评检查长三角分中心在上海正式挂牌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea302054e094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429266, encodeId=f1f7142926628, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局：以临床价值为导向，推动古代经典名方中药复方制剂研制, objectType=article, longId=205249, objectId=27c32052494e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27c32052494e, replyNumber=0, likeNumber=68, createdTime=2021-01-04, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27c32052494e, moduleTitle=国家药监局：以临床价值为导向，推动古代经典名方中药复方制剂研制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27c32052494e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429265, encodeId=8a1c14292652b, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局公开征求《药物警戒质量管理规范（征求意见稿）》意见, objectType=article, longId=204272, objectId=53412042e256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53412042e256, replyNumber=0, likeNumber=66, createdTime=2020-12-09, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53412042e256, moduleTitle=国家药监局公开征求《药物警戒质量管理规范（征求意见稿）》意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53412042e256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429264, encodeId=ada01429264b2, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局发布，真实世界数据用于医疗器械临床评价技术指导原则（试行）, objectType=article, longId=203785, objectId=9f30203e8509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f30203e8509, replyNumber=0, likeNumber=68, createdTime=2020-11-28, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f30203e8509, moduleTitle=国家药监局发布，真实世界数据用于医疗器械临床评价技术指导原则（试行）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f30203e8509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429263, encodeId=5b22142926379, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=【待证实】中国国药集团已向国家药监局提交了新冠疫苗上市申请【附评论】, objectType=article, longId=203750, objectId=c01c203e504e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01c203e504e, replyNumber=0, likeNumber=55, createdTime=2020-11-27, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01c203e504e, moduleTitle=【待证实】中国国药集团已向国家药监局提交了新冠疫苗上市申请【附评论】, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c01c203e504e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429262, encodeId=727c142926255, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局批准卫材仑伐替尼治疗甲状腺癌，这是第二个适应症, objectType=article, longId=203201, objectId=fb9120320195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb9120320195, replyNumber=0, likeNumber=85, createdTime=2020-11-11, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb9120320195, moduleTitle=国家药监局批准卫材仑伐替尼治疗甲状腺癌，这是第二个适应症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb9120320195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429261, encodeId=0ef914292610f, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局：今日起，将试点启用医疗器械电子注册证！, objectType=article, longId=202821, objectId=bcea2028219b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcea2028219b, replyNumber=0, likeNumber=78, createdTime=2020-11-04, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcea2028219b, moduleTitle=国家药监局：今日起，将试点启用医疗器械电子注册证！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcea2028219b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局关于发布球囊扩张导管等6项指导原则的通告(2020年第62号), objectType=article, longId=201522, objectId=7b992015226d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b992015226d, replyNumber=0, likeNumber=130, createdTime=2020-10-04, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b992015226d, moduleTitle=国家药监局关于发布球囊扩张导管等6项指导原则的通告(2020年第62号), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b992015226d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429259, encodeId=e5211429259c7, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局批准非激素外用PDE4抑制剂舒坦明(克立硼罗)用于特应性皮炎治疗, objectType=article, longId=198709, objectId=9e0a198e09fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e0a198e09fa, replyNumber=0, likeNumber=91, createdTime=2020-08-06, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e0a198e09fa, moduleTitle=国家药监局批准非激素外用PDE4抑制剂舒坦明(克立硼罗)用于特应性皮炎治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e0a198e09fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429258, encodeId=8c96142925837, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=定了！国家药监局发文，整治这些医械代理商, objectType=article, longId=196138, objectId=7e9d19613897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9d19613897, replyNumber=0, likeNumber=65, createdTime=2020-06-21, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9d19613897, moduleTitle=定了！国家药监局发文，整治这些医械代理商, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9d19613897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429257, encodeId=f6ed142925e48, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局：落实药品、医疗器械等“四个严格”监管要求，对违法违规行为“处罚到人”, objectType=article, longId=196042, objectId=d5cc19604262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5cc19604262, replyNumber=0, likeNumber=66, createdTime=2020-06-19, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5cc19604262, moduleTitle=国家药监局：落实药品、医疗器械等“四个严格”监管要求，对违法违规行为“处罚到人”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5cc19604262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429256, encodeId=6ca2142925626, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局开会，中药饮片大整治来了, objectType=article, longId=194441, objectId=1755194441b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1755194441b0, replyNumber=0, likeNumber=75, createdTime=2020-05-22, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1755194441b0, moduleTitle=国家药监局开会，中药饮片大整治来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1755194441b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429255, encodeId=7918142925572, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局通知，影响所有药企, objectType=article, longId=194307, objectId=cb2319430e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2319430e66, replyNumber=0, likeNumber=0, createdTime=2020-05-19, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2319430e66, moduleTitle=国家药监局通知，影响所有药企, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2319430e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429254, encodeId=61e114292548f, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局优先审评审批，新一代国产肺癌创新药上市, objectType=article, longId=193935, objectId=19e91939353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e91939353f, replyNumber=0, likeNumber=79, createdTime=2020-05-12, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e91939353f, moduleTitle=国家药监局优先审评审批，新一代国产肺癌创新药上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19e91939353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429253, encodeId=825114292533e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局出手！网络售药专项整治来了, objectType=article, longId=193048, objectId=e6d1193048e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d1193048e9, replyNumber=0, likeNumber=65, createdTime=2020-04-28, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d1193048e9, moduleTitle=国家药监局出手！网络售药专项整治来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d1193048e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429252, encodeId=b9001429252bf, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=斑块状银屑病重大进展！西安杨森Tremfya(特诺雅，古塞奇尤单抗)获国家药监局(NMPA)批准上市！, objectType=article, longId=192695, objectId=249d19269580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=249d19269580, replyNumber=0, likeNumber=67, createdTime=2020-04-23, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=249d19269580, moduleTitle=斑块状银屑病重大进展！西安杨森Tremfya(特诺雅，古塞奇尤单抗)获国家药监局(NMPA)批准上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=249d19269580)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429251, encodeId=a0f8142925134, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, objectTitle=国家药监局发文：修订脑心通制剂说明书, objectType=article, longId=192212, objectId=9a8f19221224, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a8f19221224, replyNumber=0, likeNumber=103, createdTime=2020-04-15, rootId=0, userName=pyaili, userId=8b1e4178198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a8f19221224, moduleTitle=国家药监局发文：修订脑心通制剂说明书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a8f19221224)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

国家药监局

2020-05-29

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局全新批准12款药品，3个首仿、2个首家通过一致性评价

2021-02-03

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局修订速效救心丸说明书，过敏者慎用

2021-01-23

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局：已建设疫苗信息化追溯体系基本实现上市疫苗全程追溯管理

2021-01-12

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局药品、器械审评检查长三角分中心在上海正式挂牌

2021-01-09

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局：以临床价值为导向，推动古代经典名方中药复方制剂研制

2021-01-04

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局公开征求《药物警戒质量管理规范（征求意见稿）》意见

2020-12-09

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局发布，真实世界数据用于医疗器械临床评价技术指导原则（试行）

2020-11-28

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

【待证实】中国国药集团已向国家药监局提交了新冠疫苗上市申请【附评论】

2020-11-27

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局批准卫材仑伐替尼治疗甲状腺癌，这是第二个适应症

2020-11-11

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局：今日起，将试点启用医疗器械电子注册证！

2020-11-04

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局关于发布球囊扩张导管等6项指导原则的通告(2020年第62号)

2020-10-04

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局批准非激素外用PDE4抑制剂舒坦明(克立硼罗)用于特应性皮炎治疗

2020-08-06

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

定了！国家药监局发文，整治这些医械代理商

2020-06-21

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局：落实药品、医疗器械等“四个严格”监管要求，对违法违规行为“处罚到人”

2020-06-19

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局开会，中药饮片大整治来了

2020-05-22

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局通知，影响所有药企

2020-05-19

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局优先审评审批，新一代国产肺癌创新药上市

2020-05-12

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局出手！网络售药专项整治来了

2020-04-28

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

斑块状银屑病重大进展！西安杨森Tremfya(特诺雅，古塞奇尤单抗)获国家药监局(NMPA)批准上市！

2020-04-23

pyaili (审核中...)

前往app查看评论内容

#国家药监局#

国家药监局发文：修订脑心通制剂说明书

2020-04-15

科室
- - 订阅+
  - 更多科室
工具
服务